Macrogen, Inc. (KOSDAQ:038290)
13,670
-330 (-2.36%)
May 20, 2026, 3:30 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 148.2 billion as of May 20, 2026. Its market cap has decreased by -15.57% in one year.
Market Cap
148.20B
Enterprise Value
213.69B
Revenue
195.27B
Ranking
n/a
PE Ratio
73.10
Stock Price
13,670.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has decreased from 148.29B to 148.20B, a decrease of -0.06%. That is a compound annual growth rate of -0.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 148.20B | -18.97% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoImmuneTech | 247.66B |
| EASY BIO,Inc. | 231.90B |
| JETEMA, | 209.12B |
| Genexine | 192.83B |
| Vaxcell-Bio Therapeutics | 143.96B |
| MedPacto | 141.38B |
| Amicogen | 127.03B |
| ENCell | 126.08B |